Matinas BioPharma Holdings, Inc.
MTNB
$0.19
$0.001.20%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.97% | -0.47% | -24.80% | 70.79% | -216.73% |
| Total Depreciation and Amortization | -94.59% | -22.11% | -14.41% | -9.02% | -4.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -211.50% | -78.72% | 109.88% | -92.94% | 16,961.90% |
| Change in Net Operating Assets | -391.73% | 159.64% | 27.12% | 36.38% | 3.80% |
| Cash from Operations | -14.68% | -6.10% | -2.37% | 27.07% | -0.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -95.31% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -95.31% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 0.00% |
| Issuance of Common Stock | -- | -- | 1.56% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | 0.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -1,250.00% |
| Cash from Financing | -- | -- | -9.38% | -96.05% | -1.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.74% | -11.49% | -31.74% | -173.18% | -10.83% |